#MayoClinicRadio podcast: 2/23/19

Listen: Mayo Clinic Radio 2/23/19 Structural heart disease is a problem with the tissues or valves of the heart. On the Mayo Clinic Radio podcast, Dr. Peter Pollak, director of Structural Heart Disease at Mayo Clinic's Florida campus, discusses?mitral valve disease and another structural heart disease problem, patent foramen ovale?--?a hole in the heart that [...]
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news

Related Links:

A former resident texted me this ECG, done for epigastric pain in an 18 year old.  The pain resolved immediately with treatment for acid reflux, and in the clinician's opinion was clearly GI in origin, but he wanted to know what the strange waves in the QRS were:See the unusual notching in II, III, aVF, and V2-V4.I had no idea what they were.  They reminded me of theDelayed Activation Wave associated with circumflex acute MI.See this case: https://hqmeded-ecg.blogspot.com/2018/05/is-there-delayed-activation-wave.html.But they are clearly different from this.I put it on Facebook EKG club and this is the ...
Source: Dr. Smith's ECG Blog - Category: Cardiology Authors: Source Type: blogs
Correlation between right ventricle systolic pressure (derived from moderate/severe tricuspid regurgitation) and survival of congenital diaphragmatic hernia (CDH) infants was established. We hypothesize that other non-tricuspid valve regurgitation (TR) dependent Echo parameters can predict CDH mortality. Our retrospective study included 20 CDH infants from January 2008 to September 2015. Inclusion criteria included: all CDH patients admitted to our neonatal intensive care unit. Exclusion criteria were: hereditary malformation of air ways, congenital heart disease other than patent ductus arteriosus (PDA) and/or PFO (patent...
Source: Progress in Pediatric Cardiology - Category: Cardiology Authors: Source Type: research
ConclusionsThis validation study demonstrates that 745.5 performed poorly across all ages. As 745.5 is widely used in population‐level investigations and ICD‐10‐CM perpetuates the problem, future analyses utilizing CHD codes should consider separate analysis of those identified only through code 745.5.
Source: Congenital Heart Disease - Category: Cardiology Authors: Tags: ORIGINAL ARTICLE Source Type: research
Publication date: Available online 30 May 2017 Source:Canadian Journal of Cardiology Author(s): Claudia Frankfurter, Anita W. Asgar, John G. Webb, Warren J. Cantor, James L. Velianou, François Gobeil, Albert W. Chan, Robert C. Welsh, Michael P. Love, David A. Wood, Kevin McKenzie, Eric M. Horlick Once considered a childhood disease, the number of adults living with congenital heart disease has now exceeded the number of pediatric patients. The landscape of percutaneous intervention for adult congenital heart disease (ACHD) has evolved over the last decade and has yet to be characterized in Canada. The aim of this s...
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
Discussion: EA is a rare and complex congenital cardiac malformation. There are about 80% to 90% of EA patients with combined atrial septal defect and patent foramen ovale. Sudden arterial occlusion is very rare especially in childhood. When thoracic roentgenoscopy, arterial blood gas analysis, coagulation test, and echocardiographic of lower extremity deep venous system are all normal, one should consider the possibility of a paradoxical embolism. If patients have the paradoxical embolism or worsening tricuspid regurgitation, the most suitable therapeutic regimen should be chosen according to patients’ condition. Wi...
Source: Medicine - Category: Internal Medicine Tags: Research Article: Clinical Case Report Source Type: research
IntroductionThe Policlinico di Monza (Milan, Italy) is a leader in the endovascular treatment of structural heart disease, accounting for more than 2500 procedures including transcatheter aortic valve implantation (TAVI), atrial septal defects (ASD), patent foramen ovale (PFO) and renal denervation.The team has experience with various TAVI devices and has completed more than 700 TAVI procedures. Most recently, the team incorporated the innovative Portico ™ transcatheter aortic valve system (St. Jude Medical).
Source: Radcliffe Cardiology - Category: Cardiology Authors: Source Type: research
IntroductionThe Policlinico di Monza (Milan, Italy) is a leader in the endovascular treatment of structural heart disease, accounting for more than 2500 procedures including transcatheter aortic valve implantation (TAVI), atrial septal defects (ASD), patent foramen ovale (PFO) and renal denervation.The team has experience with various TAVI devices and has completed more than 700 TAVI procedures. Most recently, the team incorporated the innovative Portico ™ transcatheter aortic valve system (St. Jude Medical).
Source: Radcliffe Cardiology - Category: Cardiology Authors: Source Type: research
Conclusion: We noted that the profile of CHD in our population was similar to the published literature although many were missed during infancy and detected later in life. Several antenatal factors were found to be associated with the incidence of congenital heart disease emphasizing the need to prioritize antenatal care and counseling to pregnant mothers along with good maternal nutrition and folic acid supplementation.
Source: Annals of Pediatric Cardiology - Category: Cardiology Authors: Source Type: research
We present an overview of the available literature that underscores the importance of hospital volume in complex structural heart disease interventions. PMID: 27152142 [PubMed]
Source: World Journal of Cardiology - Category: Cardiology Authors: Tags: World J Cardiol Source Type: research
Authors: Pineda AM, Mihos CG, Singla S, Santana O, Rhodes J, Sommer RJ, Rihal CS, Beohar N Abstract The number of adults with congenital heart disease is expected to increase over the next decade. Although acquired defects are being increasingly recognized in adults, congenital heart disease remains the most common etiology. With advances in cardiac imaging, device technology, and transcatheter techniques, percutaneous closure is now feasible and safe for most intracardiac defects. Device closure is considered the first-line therapy for a variety of congenital intracardiac defects, including ostium secundum atrial ...
Source: The Journal of Invasive Cardiology - Category: Cardiology Tags: J Invasive Cardiol Source Type: research
More News: Cardiology | Databases & Libraries | Heart | Heart Disease | Hole in the Heart | Patent Foramen Ovale | Podcasts